We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants.
Verified July 2017 by Jason Efstathiou, Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01617161
First Posted: June 12, 2012
Last Update Posted: July 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
University of Pennsylvania
National Cancer Institute (NCI)
Northwestern University
ProCure Proton Therapy Center
Washington University School of Medicine
University of Washington
Memorial Sloan Kettering Cancer Center
Rutgers Cancer Institute of New Jersey
Provision Center for Proton Therapy
Mayo Clinic
University of Maryland
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2026
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)

To Top